Consolidation treatment of advanced (FIGO stage III) ovarian carcinoma in complete surgical remission after induction chemotherapy: A randomized, controlled, clinical trial comparing whole abdominal radiotherapy, chemotherapy, and no further treatment

International Journal of Gynecological Cancer

Volumn 13, Issue 3, 2003, Pages 278-286

  Sorbe, B ^a  

^a ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Consolidation therapy; Ovarian carcinoma; Radiotherapy

Indexed keywords

CISPLATIN; DOXORUBICIN; EPIRUBICIN;

ABDOMINAL RADIOTHERAPY; ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER RECURRENCE; CANCER REGRESSION; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LAPAROTOMY; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OVARY CARCINOMA; PRIORITY JOURNAL; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; ADJUVANT CHEMOTHERAPY; COMPARATIVE STUDY; GYNECOLOGIC SURGERY; METHODOLOGY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; OVARY TUMOR; PATHOLOGY; PROSPECTIVE STUDY; RADIOTHERAPY; REMISSION; REOPERATION; SURVIVAL; TUMOR RECURRENCE;

ADULT; AGED; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; FEMALE; GYNECOLOGIC SURGICAL PROCEDURES; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OVARIAN NEOPLASMS; PROSPECTIVE STUDIES; RADIOTHERAPY; REMISSION INDUCTION; REOPERATION; SURVIVAL ANALYSIS;

EID: 0141683287     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1438.2003.13193.x     Document Type: Article

References (33)

1. Ho AG, Beller U, Speyer JL, Colombo N, Wernz J, Beckman EM. A Reassessment of the role of second-look laparotomy in advanced ovarian cancer. J Clin Oncol 1987;5:1316-21.
2. Lund B, Williamson P. Prognostic factors for outcome of and survival after second-look laparotomy in patients with advanced ovarian carcinoma. Obstet Gynecol 1990;76:617-22.
3. Rubin S, Hoskins W, Saigo P et al. Prognostic factors for recurrence following negative second-look laparotomy in ovarian cancer patients treated with platinum-based chemotherapy. Gynecol Oncol 1991;42:137-41.
4. Vermorken JB. Consolidation therapy in patients with advanced ovarian cancer. Eur J Gynaecol Oncol 1994;15:7-13.
5. MacGibbon A, Bucci J, MacLeod C et al. Whole abdominal radiotherapy following second-look laparotomy for ovarian carcinoma. Gynecol Oncol 1999;75:62-7.
6. Rothenberg ML, Liu PY, Wilczynski S et al. Phase II trial of oral altretamine for consolidation of clinical complete remission in women with stage III epithelial ovarian cancer: a Southwest Oncology Group trial (SWOG-9326). Gynecol Oncol 2001;82:317-22.
7. Markman M. Weekly paclitaxel in the management of ovarian cancer. Semin Oncol 2000;27:37-40.
8. Dembo AJ, Bush RS, Beale FA et al. Improved survival following abdominopelvic irradiation in patients with a completed pelvic operation. Am J Obstet Gynecol 1979;134:793-800.
9. Fuller DB, Sause WT, Plenk HP et al. Analysis of postoperative radiation therapy in stage I through III epithelial ovarian carcinoma. J Clin Oncol 1987;5:897-902.
10. Thomas GM. Is there a role for consolidation or salvage radiotherapy after chemotherapy in advanced epithelial ovarian cancer? Gynecol Oncol 1993;51:97-103.
11. Thomas GM, Dembo AJ. Integrating radiation therapy into the management of ovarian cancer. Cancer 1993;71:1710-8.
12. Dembo AJ. Epithelial ovarian cancer, the role of radiotherapy. Int J Radiat Oncol Biol Phys 1992;22:835-45.
13. Peters WA 3rd, Smith MR, Cain JM et al. Intraperitoneal P-32 is not an effective consolidation therapy after a negative second-look laparotomy for epithelial carcinoma of the ovary. Gynecol Oncol 1992;47:146-9.
14. Dufour P, Bergerat JP, Liu KL et al. High dose melphalan and ABMT with or without abdominal radiotherapy as consolidation treatment for ovarian carcinoma in complete remission or with microscopic residual disease. Eur J Gynaecol Oncol 1991;12:457-61.
15. Umesaki N, Tanaka T, Muso H et al. Intermittent cisplatin therapy for stage-III ovarian cancer patients following clinical remission. Gynecol Obstet Invest 1999;47:139-43.
16. Gladieff L, Chatelut E, Gaspard MH et al. Intraperitoneal high-dose chemotherapy as consolidation treatment for advanced ovarian carcinoma: a pilot study. Bull Cancer 1999;86:673-7.
17. Barakat RR, Almadrones L, Venkatraman ES et al. A phase II trial of intraperitoneal cisplatin and etoposide as consolidation therapy in patients with stage II-IV epithelial ovarian cancer following negative surgical assessment. Gynecol Oncol 1998;69:17-22.
18. Dufour P, Maloisel F, Bergerat JP et al. Intraperitoneal mitoxantrone as consolidation treatment for stage III ovarian carcinoma: a pilot study. Bull Cancer 1991;78:273-80.
19. Tarraza HM Jr, Boyce CR, Smith WG et al. Consolidation intraperitoneal chemotherapy in epithelial ovarian cancer patients following negative second-look laparotomy. Gynecol Oncol 1993;50:287-90.
20. Menczer J, Ben-Baruch G, Rizel S et al. Intraperitoneal chemotherapy versus no treatment in patients with ovarian carcinoma who are in complete clinical remission. Cancer 1992;70:1956-9.
21. Beller U, Speyer J, Colombo N et al. Consolidation with intraperitoneal cisplatin in first-line therapy of advanced ovarian cancer. J Clin Oncol 1991;9:809-17.
22. Bertucci F, Viens P, Delpero JR et al. High-dose melphalan-based chemotherapy and autologous stem cell transplantation after second-look laparotomy in patients with chemosensitive advanced ovarian carcinoma: long-term results. Bone Marrow Transplant 2000;26:61-7.
23. Ozols RF, Gore M, Tropé C, Grénman S. Intraperitoneal treatment and dose-intense therapy in ovarian cancer. Ann Oncol 1999;1:59-64.
24. McGuire WP. High-dose chemotherapy and autologous bone marrow or stem cell reconstitution for solid tumors. Curr Probl Cancer 1998;22:135-77.
25. Salerno MG, Ferrandina G, Greggi S et al. High-dose chemotherapy as a consolidation approach in advanced ovarian cancer: long-term results. Bone Marrow Transplant 2001;27:1017-25.
26. Kapp KS, Kapp DS, Poschauko J et al. The prognostic significance of peritoneal seeding and size of postsurgical residual in patients with stage III epithelial ovarian cancer treated with surgery, chemotherapy, and high-dose radiotherapy. Gynecol Oncol 1999;74:400-7.
27. Buser K, Bacchi M, Goldhirsch A et al. Treatment of ovarian cancer with surgery, short-course chemotherapy and whole abdominal radiation. Ann Oncol 1996;7:65-70.
28. Lambert HE, Rustin GJ, Gregory WM, Nelstrop AE. A randomized trial comparing single-agent carboplatin with carboplatin followed by radiotherapy for advanced ovarian cancer: a North Thames Ovary Group Study. J Clin Oncol 1993;11:440-8.
29. Pickel H, Petru E, Lahousen M et al. Consolidation radiotherapy following carboplatin-based chemotherapy in radically operated advanced ovarian cancer. A pilot study. Am J Clin Oncol 1991;14:184-7.
30. Goldhirsch A, Greiner R, Dreher E et al. Treatment of advanced ovarian cancer with surgery, chemotherapy, and consolidation of response by whole-abdominal radiotherapy. Cancer 1988;62:40-7.
31. Fuks Z, Rizel S, Biran S. Chemotherapeutic and surgical induction of pathological complete remission and whole abdominal irradiation for consolidation does not enhance the cure of stage III ovarian cancer. J Clin Oncol 1988;6:509-16.
32. Kuten A, Stein M, Steiner M, Rubinov R, Epelbaum R, Cohen Y. Whole abdominal irradiation following chemotherapy in advanced ovarian carcinoma. Int J Radiat Oncol Biol Phys 1988;14:273-9.
33. Lawton F, Luesley D, Blackledge G et al. A randomized trial comparing whole abdominal radiotherapy with chemotherapy following cisplatinum cytoreduction in epithelial ovarian cancer. West Midlands Ovarian Cancer Group trial II. Clin Oncol 1990;2:4-9.